Canon Medical Launches CT Solution to Quickly and Safely Image Patients With Viral Infectious Diseases

Deployable CT Solutions + Rapid Decontamination Can Help Hospitals Isolate Patients and Decontaminate the System for More Effective Care

In today’s challenging healthcare environment, radiology departments are often faced with the difficult decision of how to safely image patients who are suspected of being positive with infectious disease.

To help hospitals and institutions effectively utilize CT with these conditions, Canon Medical Systems USA, Inc. introduces a deployable CT with a rapid decontamination solution. The deployable system includes the Aquilion™ Prime SP CT system in a modular or mobile footprint with a rapid decontamination tool, to help isolate and decontaminate the CT for rapid, safe imaging.

The Aquilion Prime SP CT system offers complete clinical capability, with advanced imaging technology from Canon Medical’s high-end CT systems with the right balance between image quality and lower dose for every patient. The system can generate 160 unique slices per rotation with 0.35-second scanning, reducing time required to perform studies for compromised patients, and also increase throughput. With a 78-cm aperture gantry and a 660-pound patient-weight-capacity couch, the system is ideal for use in an emergency setting. The Aquilion Prime SP is now also available with Advanced Intelligent Clear-IQ Engine (AiCE) Deep Learning Reconstruction (DLR), enabling clinicians to enhance diagnostic confidence at low doses. Now available in a modular or mobile setup for easy deployment, the system can be isolated from other facility staff and patients, providing a safer environment for imaging patients suspected to have infectious diseases.

The decontamination system is an automated UV-C technology that significantly reduces bacteria, spores and viruses and is effective against a variety of advanced viral infectious diseases. The system incorporates multiple automated UV-C emitters that work together to provide decontamination of the room in minutes to help improve workflow. The decontamination system is available for the new deployable CT solutions, as well as existing fixed imaging suites.

“Imaging infectious disease patients is not a new phenomenon for medical providers. But our customers are facing an unprecedented number of potentially contagious patients,” said Erin Angel, managing director, CT Business Unit, Canon Medical Systems USA, Inc. “Our deployable CT offerings with the addition of rapid UV-C decontamination will offer providers a unique solution to help improve their workflow and safety as they image infectious disease patients.”

 

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.